l carnitine and fatty liver disease L-carnitine Could Be Beneficial in Nonalcoholic Patients by Improving Choline Metabolism Reducing Liver Biomarkers l-carnitine therapy in non-alcoholic steatohepatitis

Moving forward, robust longitudinal clinical studies, mechanistic elucidation, and personalized microbiome profiling will be critical to transforming this emerging science into actionable therapies for neurodegenerative disease

This article aims to provide a clear and medically grounded overviewfrom basic knowledge and mechanisms to safety considerations and practical guidanceso readers can make informed decisions with confidence

During power outages or refrigerator malfunctions, patients should contact their pharmacist or the medication manufacturer for guidance on temperature excursions

Mucus and cell-penetrating nanoparticles embedded in nano-into-micro formulations for pulmonary delivery of ivacaftor in patients with cystic fibrosis